Design and validation of cell-based potency assays for frataxin supplementation treatments is a research paper published in Molecular Therapy — Methods & Clinical Development (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: R01NS121038
National Institute of Neurological Disorders and Stroke
Grant: R03NS099953
National Institutes of Health
Grant: 7R01NS121038-02
Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesis
National Institutes of Health
Grant: 5R03NS099953-02
Developing models to define the Frataxin G130V-specific pathogenic mechanism in Friedreich's ataxia
Friedreich's Ataxia Research Alliance
FWCI
0.18
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals